217 related articles for article (PubMed ID: 25480831)
1. DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival.
Cornell L; Munck JM; Alsinet C; Villanueva A; Ogle L; Willoughby CE; Televantou D; Thomas HD; Jackson J; Burt AD; Newell D; Rose J; Manas DM; Shapiro GI; Curtin NJ; Reeves HL
Clin Cancer Res; 2015 Feb; 21(4):925-33. PubMed ID: 25480831
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value.
Evert M; Frau M; Tomasi ML; Latte G; Simile MM; Seddaiu MA; Zimmermann A; Ladu S; Staniscia T; Brozzetti S; Solinas G; Dombrowski F; Feo F; Pascale RM; Calvisi DF
Br J Cancer; 2013 Nov; 109(10):2654-64. PubMed ID: 24136149
[TBL] [Abstract][Full Text] [Related]
3. DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?
Pascale RM; Joseph C; Latte G; Evert M; Feo F; Calvisi DF
DNA Repair (Amst); 2016 Nov; 47():12-20. PubMed ID: 27789167
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 Inhibitor STA9090 Sensitizes Hepatocellular Carcinoma to Hyperthermia-Induced DNA Damage by Suppressing DNA-PKcs Protein Stability and mRNA Transcription.
Liu L; Deng Y; Zheng Z; Deng Z; Zhang J; Li J; Liang M; Zhou X; Tan W; Yang H; Neckers LM; Zou F; Chen X
Mol Cancer Ther; 2021 Oct; 20(10):1880-1892. PubMed ID: 34376581
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
6. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
[TBL] [Abstract][Full Text] [Related]
7. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
[TBL] [Abstract][Full Text] [Related]
8. Tumor DNA-dependent protein kinase catalytic subunit expression is associated with hepatitis B surface antigen status and tumor progression in patients with hepatocellular carcinoma.
Shimizu T; Aoki T; Mori S; Iso Y; Kato M; Ishizuka M; Kubota K
Sci Rep; 2018 Oct; 8(1):15019. PubMed ID: 30301934
[TBL] [Abstract][Full Text] [Related]
9. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma.
Liu Z; Ye Q; Wu L; Gao F; Xie H; Zhou L; Zheng S; Xu X
Mol Carcinog; 2018 Nov; 57(11):1435-1444. PubMed ID: 29873415
[TBL] [Abstract][Full Text] [Related]
11. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.
Liu Z; Li J; Chen J; Shan Q; Dai H; Xie H; Zhou L; Xu X; Zheng S
BMC Cancer; 2018 Feb; 18(1):200. PubMed ID: 29463213
[TBL] [Abstract][Full Text] [Related]
12. The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.
Pang YY; Li JD; Gao L; Yang X; Dang YW; Lai ZF; Liu LM; Yang J; Wu HY; He RQ; Huang ZG; Xiong DD; Yang LH; Shi L; Mo WJ; Tang D; Lu HP; Chen G
Cancer Med; 2020 Nov; 9(21):8004-8019. PubMed ID: 32931665
[TBL] [Abstract][Full Text] [Related]
13. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
[TBL] [Abstract][Full Text] [Related]
14. [Expression of DNA-PK in hepato- and cholangio-neoplasms and its significance].
Yu ZJ; Sui JG; Ding YQ; Cao ZS; Zhou PK; Wu DC
Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):652-5. PubMed ID: 15623371
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
[TBL] [Abstract][Full Text] [Related]
16. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
Liu H; Wang X; Feng B; Tang L; Li W; Zheng X; Liu Y; Peng Y; Zheng G; He Q
BMC Cancer; 2018 Jun; 18(1):661. PubMed ID: 29914442
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing.
Jiang JH; Liu YF; Ke AW; Gu FM; Yu Y; Dai Z; Gao Q; Shi GM; Liao BY; Xie YH; Fan J; Huang XW; Zhou J
Hepatology; 2014 Jun; 59(6):2216-27. PubMed ID: 24425307
[TBL] [Abstract][Full Text] [Related]
18. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis.
Zhu Q; Gong L; Liu X; Wang J; Ren P; Zhang W; Yao L; Han X; Zhu S; Lan M; Li Y; Zhang W
Diagn Pathol; 2015 Jun; 10():70. PubMed ID: 26076954
[TBL] [Abstract][Full Text] [Related]
20. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]